Find and Pitch Jounalists, Get Your Story Covered

Tags: metformin dementia opioid methadone tobacco

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease - 17 days ago Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain - 2 months ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 6 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 7 months ago FDA Approves First-Ever Drug for Serious Liver Condition - 12 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - about 1 year ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - about 1 year ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - about 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago Methotrexate Tied to Greater Risks for Older Patients With CKD - over 1 year ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - over 1 year ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - over 1 year ago Another Study Highlights Metformin's Dementia Protection Properties - over 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - over 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - over 1 year ago Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk - over 1 year ago Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes - over 1 year ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 21 days ago To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 11 months ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more - 2 months ago STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 8 months ago STAT+: Pharmalittle: We’re reading about a Pfizer daily weight loss pill, a Novo Nordisk setback, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more - 12 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 12 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - over 1 year ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - over 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - over 1 year ago STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - over 1 year ago
4	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Noom Launches Oral Medication Offering for Weight Loss - 3 months ago
5	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 3 months ago
6	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 3 months ago
7	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	IG Live December 2: The Weight of Wegovy - 3 months ago
8	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - 3 months ago FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 4 months ago Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers - about 1 year ago
9	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Metformin Use Linked to Fewer Asthma Attacks - 3 months ago
10	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - 4 months ago STAT+: Lilly’s Zepbound slashed risk of developing diabetes - 7 months ago STAT+: Positive trial results set up obesity drug Wegovy for use against heart failure - 11 months ago

Journalists covering metformin